Johnson & Johnson stock rises as JNJ gets fresh price-target bump — what investors watch next
Johnson & Johnson shares rose 1.7% to $225.19 Tuesday afternoon, outperforming the healthcare sector after Freedom Capital raised its price target to $220 but kept a “Hold” rating. The move followed an earnings report projecting 2026 profit and sales above Wall Street estimates, with investors watching for regulatory updates and litigation risks.